Limbix' digital therapeutic cuts depression symptoms in youn...

Limbix is moving ahead with plans to file for FDA approval of its SparkRx digital therapeutic (DTx) for adolescents with symptoms of depression after reporting positive results in a clinica

MHRA clears Moderna COVID vaccine for 12 to 17 year olds

The Moderna COVID-19 vaccine has become the second jab to be authorised for use in England, Scotland and Wales in children aged 12 to 17 after getting the nod from the Medicines and healthc

Pfizer’s Revatio flunks paediatric hypertension study

FDA and EMA to work more closely on paediatric drug regulati...

FDA and EMA hope to streamline development of paediatric plans.